Diane J Burgess Selected Research

Diane J Burgess Research Topics

Disease

16	Inflammation (Inflammations) 01/2022 - 12/2004
9	Foreign-Body Reaction 01/2022 - 01/2007
9	Foreign Bodies (Foreign Body) 01/2022 - 01/2010
8	Fibrosis (Cirrhosis) 09/2015 - 12/2004
7	Neoplasms (Cancer) 05/2022 - 01/2015
4	Breast Neoplasms (Breast Cancer) 01/2015 - 07/2012
3	Pain (Aches) 02/2021 - 04/2018
2	Stomatitis 02/2021 - 04/2020
2	Anaphylaxis (Anaphylactic Shock) 01/2020 - 10/2019
1	Chronic Disease (Chronic Diseases) 10/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021
1	Glioma (Gliomas) 12/2019
1	Hypersensitivity (Allergy) 10/2019
1	Knee Injuries (Knee Injury) 04/2018
1	Knee Osteoarthritis 04/2018
1	Osteoarthritis 04/2018
1	Ischemia 10/2016
1	Wounds and Injuries (Trauma) 08/2015
1	Disease Progression 04/2005

Drug/Important Bio-Agent (IBA)

17	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 12/2004
13	Pharmaceutical PreparationsIBA 05/2022 - 12/2004
9	HydrogelsIBA 01/2021 - 12/2004
8	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2021 - 12/2004
7	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2011
6	Liposomes (Liposome)IBA 05/2022 - 07/2012
4	LipidsIBA 05/2022 - 07/2012
4	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2018 - 01/2007
3	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2022 - 01/2007
3	CollagenIBA 10/2021 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 01/2007
2	SolutionsIBA 01/2022 - 01/2010
2	Polyvinyl AlcoholIBA 01/2021 - 02/2013
2	Biological ProductsIBA 11/2020 - 04/2005
2	cyclic arginine-glycine-aspartic acid peptideIBA 01/2020 - 10/2019
2	Peptides (Polypeptides)IBA 01/2020 - 12/2019
2	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2015
2	Small Interfering RNA (siRNA)IBA 04/2013 - 07/2012
2	CalciumIBA 08/2012 - 07/2012
1	Insulin (Novolin)FDA Link 10/2021
1	Blood Glucose (Blood Sugar)IBA 10/2021
1	Amyloid (Amyloid Fibrils)IBA 10/2021
1	Dosage Forms (Dosage Form)IBA 02/2021
1	GelsIBA 02/2021
1	Hormones (Hormone)IBA 09/2020
1	Linoleic Acid (Linoleate)IBA 04/2020
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 04/2020
1	Drug CarriersIBA 01/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020
1	MicellesIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Endoplasmic Reticulum Chaperone BiPIBA 12/2019
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2019
1	peptide E (adrenal medulla)IBA 10/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2019
1	Immunoglobulin G (IgG)IBA 10/2019
1	AnaphylatoxinsIBA 10/2019
1	Immunoglobulin E (IgE)IBA 10/2019
1	CytokinesIBA 10/2019
1	SiliconIBA 11/2018
1	Saline SolutionIBA 04/2018
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 04/2018
1	Adenosine Diphosphate (ADP)IBA 04/2018
1	FX006IBA 04/2018
1	Levodopa (L Dopa)FDA LinkGeneric 10/2016
1	polyvinyl alcohol hydrogelIBA 09/2015
1	Capsules (Microcapsules)IBA 08/2015
1	calcium phosphateIBA 01/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2015
1	Antifibrotic AgentsIBA 01/2015
1	PolymersIBA 08/2013
1	Proteoglycans (Proteoglycan)IBA 04/2013
1	Heparin (Liquaemin)FDA LinkGeneric 04/2013
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 04/2013
1	Sulfates (Sulfates, Inorganic)IBA 04/2013
1	IonsIBA 07/2012
1	1,2- dioleoyl- sn- glycero- 3- phosphoglycerol (DOPG)IBA 07/2012
1	Biocompatible Materials (Biomaterials)IBA 06/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2008
1	DNA (Deoxyribonucleic Acid)IBA 04/2005

Therapy/Procedure

13	Microspheres (Microsphere) 01/2021 - 12/2004
4	Therapeutics 05/2022 - 01/2015
2	Catheters 01/2022 - 10/2021
2	Drug Therapy (Chemotherapy) 11/2020 - 12/2019
1	Immunotherapy 11/2020
1	Intravenous Injections 01/2020
1	Subcutaneous Injections 01/2020
1	Intra-Articular Injections 04/2018